Hospital de Cabueñes-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2023

  1. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031

  2. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  3. Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry

    Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 4, pp. 608-619

  4. Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

    Haematologica, Vol. 108, Núm. 10, pp. 2753-2763

  5. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2021

  1. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  2. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  3. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2019

  1. Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

    Leukemia, Vol. 33, Núm. 5, pp. 1256-1267

  2. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2017

  1. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

    Hematological Oncology, Vol. 35, Núm. 4, pp. 520-527

2016

  1. Acral peeling skin syndrome resulting from mutations in TGM5

    Journal of the European Academy of Dermatology and Venereology

  2. Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

    Blood, Vol. 127, Núm. 24, pp. 3035-3039

2015

  1. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: Results of the PRO-R-IPI study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 15, Núm. 7, pp. 398-403

  2. Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy

    Leukemia and Lymphoma, Vol. 56, Núm. 11, pp. 3096-3102

2014

  1. Lymphomatoid granulomatosis of central nervous system and lung driven by Epstein Barr virus proliferation: Successful treatment with rituximab-containing chemotherapy

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6, Núm. 1